• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对来自巴西亚马逊地区疟疾感染个体中天然存在的抗疟原虫 vivax 裂殖子表面蛋白 3α(PvMSP-3α)的 B 细胞表位进行分析和鉴定。

B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.

机构信息

Laboratory of Immunoparasitology, Institute Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil.

出版信息

Vaccine. 2011 Feb 17;29(9):1801-11. doi: 10.1016/j.vaccine.2010.12.099. Epub 2011 Jan 6.

DOI:10.1016/j.vaccine.2010.12.099
PMID:21215342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3065243/
Abstract

The Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) is considered as a potential vaccine candidate. However, the detailed investigations of the type of immune responses induced in naturally exposed populations are necessary. Therefore, we aim to characterize the naturally induced antibody to PvMSP-3α in 282 individuals with different levels of exposure to malaria infections residents in Brazilian Amazon. PvMSP3 specific antibodies (IgA, IgG and IgG subclass) to five recombinant proteins and the epitope mapping by Spot-synthesis technique to full-protein sequence of amino acids (15aa sequence with overlapping sequence of 9aa) were performed. Our results indicates that PvMSP3 is highly immunogenic in naturally exposed populations, where 78% of studied individuals present IgG immune response against the full-length recombinant protein (PVMSP3-FL) and IgG subclass profile was similar to all five recombinant proteins studied with a high predominance of IgG1 and IgG3. We also observe that IgG and subclass levels against PvMSP3 are associated with malaria exposure. The PvMSP3 epitope mapping by Spot-synthesis shows a natural recognition of at least 15 antigenic determinants, located mainly in the two blocks of repeats, confirming the high immunogenicity of this region. In conclusion, PvMSP-3α is immunogenic in naturally exposed individuals to malaria infections and that antibodies to PvMSP3 are induced to several B cell epitopes. The presence of PvMSP3 cytophilic antibodies (IgG1 and IgG3), suggests that this mechanism could also occur in P. vivax.

摘要

疟原虫 vivax 裂殖子表面蛋白-3α(PvMSP-3α)被认为是一种有潜力的疫苗候选物。然而,有必要对自然暴露人群中诱导的免疫反应类型进行详细研究。因此,我们旨在对 282 名居住在巴西亚马逊地区的疟疾感染自然暴露人群中对 PvMSP-3α 产生的自然诱导抗体进行特征分析。对五种重组蛋白的 PvMSP3 特异性抗体(IgA、IgG 和 IgG 亚类)和通过斑点合成技术对全长氨基酸序列(15aa 序列重叠 9aa)的表位作图进行了研究。结果表明,PvMSP3 在自然暴露人群中具有高度免疫原性,78%的研究个体对全长重组蛋白(PVMSP3-FL)产生 IgG 免疫反应,且 IgG 亚类谱与所研究的所有五种重组蛋白相似,以 IgG1 和 IgG3 的高优势为主。我们还观察到,针对 PvMSP3 的 IgG 和亚类水平与疟疾暴露相关。斑点合成的 PvMSP3 表位作图显示,至少有 15 个抗原决定簇被自然识别,这些决定簇主要位于重复区的两个块中,证实了该区域的高免疫原性。总之,PvMSP-3α 在自然暴露于疟疾感染的个体中具有免疫原性,针对 PvMSP3 的抗体可诱导出多个 B 细胞表位。PvMSP3 细胞亲嗜性抗体(IgG1 和 IgG3)的存在表明,这种机制也可能发生在 P. vivax 中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/3318b3097ca2/nihms266095f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/1df6988177eb/nihms266095f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/2319e163d351/nihms266095f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/95eda1464a7d/nihms266095f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/d3db4833814b/nihms266095f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/3318b3097ca2/nihms266095f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/1df6988177eb/nihms266095f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/2319e163d351/nihms266095f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/95eda1464a7d/nihms266095f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/d3db4833814b/nihms266095f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e63/3065243/3318b3097ca2/nihms266095f5.jpg

相似文献

1
B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.对来自巴西亚马逊地区疟疾感染个体中天然存在的抗疟原虫 vivax 裂殖子表面蛋白 3α(PvMSP-3α)的 B 细胞表位进行分析和鉴定。
Vaccine. 2011 Feb 17;29(9):1801-11. doi: 10.1016/j.vaccine.2010.12.099. Epub 2011 Jan 6.
2
Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.人群感染疟原虫 vivax 血期疫苗候选抗原(PvMSP-1₁₉ 和 PvMSP-3α₃₅₉₋₇₉₈)产生的抗体及其与巴西亚马逊地区疟疾患者血液学特征的关系。
Microbes Infect. 2012 Aug;14(9):730-9. doi: 10.1016/j.micinf.2012.02.011. Epub 2012 Mar 8.
3
Antibody Responses Against TRAP Recombinant and Synthetic Antigens in Naturally Exposed Individuals From the Brazilian Amazon.巴西亚马逊自然暴露人群中针对 TRAP 重组和合成抗原的抗体反应。
Front Immunol. 2019 Sep 20;10:2230. doi: 10.3389/fimmu.2019.02230. eCollection 2019.
4
Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.疟原虫 AMA-1 和 MSP-9 的主要 B 细胞表位是自然获得的抗体和感染疟原虫后急性和恢复期记忆性 B 细胞的靶标。
Parasite Immunol. 2020 May;42(5):e12705. doi: 10.1111/pim.12705. Epub 2020 Mar 19.
5
Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection.抗恶性疟原虫裂殖子表面蛋白 3γ(PvMSP3γ)抗体在自然感染时产生。
Sci Rep. 2024 Apr 26;14(1):9595. doi: 10.1038/s41598-024-59153-w.
6
Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.巴西东北部亚马逊地区流行地区个体对间日疟原虫 MSP-1₁₉疫苗候选物的细胞和体液免疫反应。
Malar J. 2013 Sep 16;12:326. doi: 10.1186/1475-2875-12-326.
7
In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.间日疟原虫疟疾疫苗候选物裂殖子表面蛋白-9线性且具有天然免疫原性的B细胞表位的计算机鉴定与验证
PLoS One. 2016 Jan 20;11(1):e0146951. doi: 10.1371/journal.pone.0146951. eCollection 2016.
8
Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.间日疟原虫裂殖子表面蛋白 3 的抗原性和免疫原性。
PLoS One. 2013;8(2):e56061. doi: 10.1371/journal.pone.0056061. Epub 2013 Feb 14.
9
Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.巴西流行地区个体中 HLA-DRB1 和 HLA-DQB1 等位基因对 IgG 抗体应答 P. vivax MSP-1、MSP-3α 和 MSP-9 的影响。
PLoS One. 2012;7(5):e36419. doi: 10.1371/journal.pone.0036419. Epub 2012 May 23.
10
Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.在印度三个地理上不同的疟疾流行地区,两种主要的间日疟原虫候选疫苗抗原的抗体反应。
Malar J. 2019 Dec 16;18(1):425. doi: 10.1186/s12936-019-3066-6.

引用本文的文献

1
Identification and serological responses to a novel merozoite surface protein 1 (MSP-1) derived synthetic peptide: a putative biomarker for malaria exposure.鉴定和血清学反应新型裂殖子表面蛋白 1(MSP-1)衍生合成肽:一种潜在的疟疾暴露生物标志物。
PeerJ. 2024 Jun 25;12:e17632. doi: 10.7717/peerj.17632. eCollection 2024.
2
Anti-Plasmodium vivax merozoite surface protein 3 ϒ (PvMSP3 ϒ) antibodies upon natural infection.抗恶性疟原虫裂殖子表面蛋白 3γ(PvMSP3γ)抗体在自然感染时产生。
Sci Rep. 2024 Apr 26;14(1):9595. doi: 10.1038/s41598-024-59153-w.
3
vaccine: What is the best way to go?

本文引用的文献

1
Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.巴西亚马逊地区自然感染疟疾的个体中,恶性疟原虫裂殖子表面蛋白 9(PvMSP9)的混杂 T 细胞表位诱导产生 IFN-γ 和 IL-4 反应。
Vaccine. 2010 Apr 19;28(18):3185-91. doi: 10.1016/j.vaccine.2010.02.046. Epub 2010 Feb 26.
2
Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.利用多重分析方法研究巴西和巴布亚新几内亚流行地区人群对间日疟原虫 MSP1 蛋白 N 端和 C 端的天然体液免疫应答。
Malar J. 2010 Jan 21;9:29. doi: 10.1186/1475-2875-9-29.
3
疫苗:哪种途径最好?
Front Immunol. 2023 Jan 16;13:910236. doi: 10.3389/fimmu.2022.910236. eCollection 2022.
4
Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients.伊朗疟疾患者对间日疟原虫可溶性重组环子孢子蛋白-VK210(rPvCSP-VK210)的血清学反应。
Eur J Med Res. 2021 Nov 25;26(1):134. doi: 10.1186/s40001-021-00607-6.
5
Diagnostic Methods for Non-Falciparum Malaria.非恶性疟原虫疟疾的诊断方法。
Front Cell Infect Microbiol. 2021 Jun 17;11:681063. doi: 10.3389/fcimb.2021.681063. eCollection 2021.
6
High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malaria.高维液质流式细胞术鉴定 T 细胞和 B 细胞特征,可预测降低患间日疟原虫疟疾的风险。
JCI Insight. 2021 Jul 22;6(14):e148086. doi: 10.1172/jci.insight.148086.
7
Alternative Invasion Mechanisms and Host Immune Response to Malaria: Trends and Future Directions.疟疾的替代入侵机制与宿主免疫反应:趋势与未来方向
Microorganisms. 2020 Dec 23;9(1):15. doi: 10.3390/microorganisms9010015.
8
Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes.对间日疟原虫分离株的全基因组测序揭示了红细胞结合基因中频繁的序列和结构多态性。
PLoS Negl Trop Dis. 2020 Oct 12;14(10):e0008234. doi: 10.1371/journal.pntd.0008234. eCollection 2020 Oct.
9
Insights into the molecular diversity of Plasmodium vivax merozoite surface protein-3γ (pvmsp3γ), a polymorphic member in the msp3 multi-gene family.深入了解疟原虫裂殖子表面蛋白 3γ(pvmsp3γ)的分子多样性,该蛋白是 msp3 多基因家族中的一个多态成员。
Sci Rep. 2020 Jul 3;10(1):10977. doi: 10.1038/s41598-020-67222-z.
10
Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.诱导和补体固定抗体对恶性疟原虫裂殖子表面蛋白 3α的动力学与免疫球蛋白 G 亚类和免疫球蛋白 M 的关系。
J Infect Dis. 2019 Nov 6;220(12):1950-1961. doi: 10.1093/infdis/jiz407.
Acquired immune response to defined Plasmodium vivax antigens in individuals residing in northern India.在印度北部居住的个体对明确的间日疟原虫抗原产生获得性免疫反应。
Microbes Infect. 2010 Mar;12(3):199-206. doi: 10.1016/j.micinf.2009.12.006. Epub 2009 Dec 23.
4
Genetic structure of Plasmodium vivax isolates from two malaria endemic areas in Afghanistan.从阿富汗两个疟疾流行地区分离的间日疟原虫的遗传结构。
Acta Trop. 2010 Jan;113(1):12-9. doi: 10.1016/j.actatropica.2009.08.025. Epub 2009 Aug 28.
5
[Plasmodium vivax infection: not so benign].[间日疟原虫感染:并非如此良性]
Med Sci (Paris). 2009 Jun-Jul;25(6-7):622-6. doi: 10.1051/medsci/2009256-7622.
6
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.间日疟原虫疟疾的新进展:重症疾病与氯喹耐药性的上升
Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1.
7
How benign is benign tertian malaria?良性三日疟的良性程度如何?
J Vector Borne Dis. 2009 Jun;46(2):141-4.
8
Vivax malaria: a major cause of morbidity in early infancy.间日疟:婴儿早期发病的主要原因。
Clin Infect Dis. 2009 Jun 15;48(12):1704-12. doi: 10.1086/599041.
9
Antibody epitope mapping using SPOT peptide arrays.使用SPOT肽阵列进行抗体表位图谱分析。
Methods Mol Biol. 2009;524:145-67. doi: 10.1007/978-1-59745-450-6_11.
10
Plasmodium vivax: who cares?间日疟原虫:谁在乎呢?
Malar J. 2008 Dec 11;7 Suppl 1(Suppl 1):S9. doi: 10.1186/1475-2875-7-S1-S9.